about
Interaction between drug and placebo effects: a cross-over balanced placebo design trial.Separation and determination of process-related impurities of industrial chlorpyriphos by reversed-phase high-performance liquid chromatography.Detection of the adulteration of traditional alcoholic beverages by the separation and determination of alprazolam, chloralhydrate and diazepam using reversed-phase high-performance liquid chromatography.Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.Preparative isolation and characterization of some minor impurities of astaxanthin by high-performance liquid chromatography.Development and validation of an HPLC method for the determination of gatifloxacin stability in human plasma.Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.Large Intra-subject Variability in Caffeine Pharmacokinetics: Randomized Cross-over Study of Single Caffeine Product.Validated HPLC method for determination of caffeine level in human plasma using synthetic plasma: application to bioavailability studies.A Simple Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Measurement of Cortisol Level in Human SalivaGas chromatographic-mass spectrometric separation, identification and determination of C6-C12 cyclic imides in thermally treated epoxy and alkyd resins to locate hot spots inside large electricity generatorsVitamin D content in fortified low fat milk in Saudi Arabia
P50
Q34372432-1EB29B3B-D78D-4254-B5D9-E512DE86FB2BQ44262160-127F59D6-B737-4C4F-929E-882965FAC7D9Q44823591-5FB4184B-5272-4ACD-AB89-D7A748163AFDQ45144230-D53C7CC8-1758-4435-A1DB-E4B7EE08544CQ46562876-7B5EF5CD-5D08-4346-879C-2245125AF037Q46823033-450693C3-6CEB-4F5E-AE46-56B4CD32E14FQ47114415-B7FA7566-E2E3-4AE9-AE7F-04AF0BFB421AQ50611321-7AB702EC-B79F-4F07-85B8-DE8053D78CA4Q53082552-074E4BEF-489B-4E4B-9EB4-5398F928A800Q64070985-85E290B4-7350-4A8D-AA87-9B3AA0B38968Q73250489-5FA73A3F-61EC-4944-B94B-39256A6A9830Q88498085-E16D04F6-CD5F-4666-AC7F-3C6CED3ED66E
P50
description
researcher
@en
wetenschapper
@nl
name
S N Alvi
@en
S N Alvi
@nl
type
label
S N Alvi
@en
S N Alvi
@nl
prefLabel
S N Alvi
@en
S N Alvi
@nl
P106
P31
P496
0000-0002-5679-1820